Moreover, these cells can undergo RIPK3-dependent cell death upon treatment with lipopolysaccharide (LPS, TLR4 agonist) [55], oxidized LDL (which is recognized by TLR4) [56], or upon certain viral infections [57,58]. Here, TLR4 is linked to viral infectious disease.